Latest Posts

Taishin International Bank Opens Flagship Private Banking Branch in Southern Taiwan

Alebund Pharmaceuticals Announces Poster Presentation by Partner R1 Therapeutics of Global Phase IIb Multi-Regional Clinical Trial Design for AP306 at ASN Kidney Week 2026

Financial Report July – September 2026

Angel Yeast Marks 40th Anniversary, Setting Its Sights on Becoming a Global Biotech Powerhouse

SHARE

← All PR Newswire releases

Source: PR Newswire · Angel Yeast · View original release

YICHANG, China, Oct. 23, 2026 /PRNewswire/ — Angel Yeast (SSE: 600298), one of the world’s leading yeast manufacturers, has hosted the 2026 International Synthetic Biology Symposium and the Angel Group High-Quality Development Conference in Yichang, its headquarters city, on October 19–20, 2026, as part of the company’s 40th anniversary celebrations.

Angel Yeast 40th Anniversary High-Quality Development Conference
Angel Yeast 40th Anniversary High-Quality Development Conference

As a highlight of Angel Yeast’s 40th anniversary, the event convened over 500 global industry partners, including academicians, experts, scholars, supplier representatives, and customer delegates from China and abroad. It offered a platform to discuss biomanufacturing and synthetic biology trends, industrial innovation, and global supply chain collaboration, showcasing Angel Yeast’s strategy of deepening international cooperation through innovation, openness, and localized operations.

The event was both a celebration of Angel Yeast’s journey and a launchpad for global partners to deepen biomanufacturing collaboration and shape future growth together.

At the High-Quality Development Conference, Angel Yeast reflected on its journey from starting as an edible yeast pilot base to becoming the world’s second-largest producer by sales volume. Today, its products reach 170+ countries and regions, serving 30,000+ customers worldwide with over 20% market share.

In innovation, Angel Yeast has built an industrial microbial strain bank and mastered key technologies in strain selection, cell factory construction and multi-carbon source fermentation. The company invests over USD 149.8 million in R&D annually, employs more than 1,500 researchers, and collaborates with over 70 research institutes worldwide.

Angel Yeast has cumulatively obtained 534 authorized invention patents, with 12 scientific and technological achievements reaching international leading levels. The company has continuously optimized its market layout and refined a research-and-sales synergy mechanism adapted to its new development stage composing of 4 business segments, 6 overseas business divisions and 8 technology centers.

Globally, Angel Yeast operates a multi-regional production and R&D network. Its Egypt plant, after two expansions, is now the world’s largest yeast factory, while its new Indonesia plant is set to begin production in Q1 next year. Overseas factories and subsidiaries employ nearly 2,000 foreign staff, with a localization rate exceeding 95%.

Angel Yeast is committed to a circular economy industrial chain: raw materials sourced from agricultural processing, core products serving food health and safety, and by-products feeding back into agriculture. It has built five National Green Factories and one zero-carbon factory, with its Ecovadis rating in the global top 15%. The company also participates in setting international standards, including the Codex Alimentarius standard for yeast products, driving the coordinated global expansion of its products, technologies, standards, and brand.

“Looking ahead, Angel Yeast will vigorously develop new synthetic biology technologies, focusing on new tracks such as future foods, biomedicine, enzyme catalysis and new materials, and agricultural microbiology. We will build a ‘biomanufacturing+’ industrial cluster, continuously propel the industrial chain toward the high end of the value chain, and strive to build a world-class biotechnology company,” remarked Xiong Tao, Chairman of Angel Yeast.

Posted in

RELATED ARTICLES

Taishin International Bank Opens Flagship Private Banking Branch in Southern Taiwan

Source: PR Newswire · Taishin International Bank (Taishin Bank) · View original releaseStrategic alliance with Switzerland's UBP brings global investment expertise and international wealth management...

Alebund Pharmaceuticals Announces Poster Presentation by Partner R1 Therapeutics of Global Phase IIb Multi-Regional Clinical Trial Design for AP306 at ASN Kidney Week 2026

Source: PR Newswire · Alebund Pharmaceuticals · View original releaseSHANGHAI, Oct. 23, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; HKEX: 09637),...

Financial Report July – September 2026

Source: PR Newswire · Autoliv · View original releaseSTOCKHOLM, Oct. 23, 2026 /PRNewswire/ -- Q3 2026: Solid performance in a tough environment Financial highlights Q3...

HKEX Launches AI Index, Southern Asset Management Authorised to Launch ETF

Source: PR Newswire · CSOP Asset Management · View original release HONG KONG, Oct. 23, 2026 /PRNewswire/ -- Hong Kong Exchanges and Clearing Limited (HKEX)...

The Westin Resort & Spa Ubud, Bali Welcomes 2027 with a Celebration of Culture and Connection

Source: PR Newswire · The Westin Resort & Spa Ubud, Bali · View original releaseBALI, Indonesia, Oct. 23, 2026 /PRNewswire/ -- As the world prepares...

JJ Lin Headlines the Singapore Grand Prix 2026 with a World-Class Show Featuring 20 Songs and a New Single Premiere; More Than 100 Team Members Gather in Singapore

Source: PR Newswire · JFJ Productions · View original releaseSINGAPORE, Oct. 23, 2026 /PRNewswire/ -- Mandopop superstar JJ Lin (an artiste under JFJ Productions) took...

Taishin International Bank Opens Flagship Private Banking Branch in Southern Taiwan

Source: PR Newswire · Taishin International Bank (Taishin Bank) · View original releaseStrategic alliance with Switzerland's UBP brings global investment expertise and international wealth management...

Alebund Pharmaceuticals Announces Poster Presentation by Partner R1 Therapeutics of Global Phase IIb Multi-Regional Clinical Trial Design for AP306 at ASN Kidney Week 2026

Source: PR Newswire · Alebund Pharmaceuticals · View original releaseSHANGHAI, Oct. 23, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; HKEX: 09637),...

Financial Report July – September 2026

Source: PR Newswire · Autoliv · View original releaseSTOCKHOLM, Oct. 23, 2026 /PRNewswire/ -- Q3 2026: Solid performance in a tough environment Financial highlights Q3...

Don't Miss

image

World Cup Fans Hear About the Greatest Victory Through Jesus

Screen Shot 2026-07-09 at 11.47.07 AM

GAME ON: SPORTS ANIME TO WATCH DURING THE FIFA WORLD CUP ON CRUNCHYROLL

image

Christian Athletes Bring Their Faith to the World Cup Stage

image

Standing Amid the Storm: Indiana Crucifix Inspires Hope